Peer Review History
| Original SubmissionMarch 9, 2026 |
|---|
|
Dear Dr. Valentim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 20 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Angelica Espinosa Miranda, M.D., Ph.D. Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for your submission to PLOS One. We note that your cover letter mentions an article with the title "“Territorial Determinants, Social Vulnerability, and Healthcare Access in Quilombola Communities in the Brazilian Amazon", but the main manuscript's title is "Healthcare Access Inequalities in Quilombola, Rural, and Riverside Communities in the Brazilian Amazon: Social, Organizational, and Territorial Determinants". Can you please clarify which is the correct title and check if you have submitted an incorrect cover letter or incorrect manuscript file? If one is incorrect please upload the correct file. 3. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. Thank you for stating the following in the Competing Interests section: “NO authors have competing interests” We note that one or more of the authors are employed by a commercial company: Academic of the Metropolitan College of Pará – FAMETRO, Santarém, Pará, Brasil and Academic of the University of Amazonia – UNAMA, Santarém, Pará, Brasil 1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This manuscript addresses a relevant and timely topic, focusing on healthcare access inequalities in vulnerable populations in the Brazilian Amazon, particularly among quilombola, rural, and riverside communities. The use of primary data collected in hard-to-reach settings represents an important strength, and the attempt to integrate individual, organizational, and territorial dimensions is commendable. However, despite its relevance, the manuscript presents important conceptual, methodological, and reporting limitations that affect the interpretability and robustness of the findings. Recommendation: Major Revision Substantial revisions are required to improve conceptual clarity, methodological justification, and adherence to reporting standards such as the: STROBE Statement. Major Comments: 1 - Misalignment between the study objective and design. The manuscript aims to “identify determinants” of healthcare access. However, given the cross-sectional design, this wording overstates the analytical capacity of the study. Cross-sectional studies do not establish temporality and are not suited to identifying determinants in a causal sense. The objective should be revised to reflect the exploratory and associative nature of the analysis. 2- Conceptual fragility of the primary outcome (“healthcare access”) The outcome is based on self-reported receipt of care when needed, which may conflate need, demand, and access, and is subject to recall and reporting bias. A stronger conceptual framework is required to support this operationalization and avoid overinterpretation.3- Insufficient discussion of potential biases Key sources of bias are not adequately addressed, including: selection bias (community-based recruitment), information bias (self-reported measures).Minor Comments (methodologically relevant): 4- Absence of descriptive table of sample characteristics: The Results section lacks a comprehensive table describing the study population. This limits interpretability and assessment of external validity. Inclusion is recommended in accordance with the STROBE Statement. 5 - Potential overinterpretation of community-level findings: Findings based on aggregated data should be interpreted cautiously, considering the limited number of communities and the risk of ecological inference. Final Assessment: The manuscript addresses an important public health issue and is based on valuable primary data. However, the main limitation lies in the misalignment between the complexity of the analytical approach and the conceptual and methodological consistency of the study. At present, the study appears to overextend its conclusions relative to its design and analytical capacity. Addressing these issues—particularly regarding the study objective, outcome definition, analytical coherence, and reporting transparency—is essential for improving the scientific contribution of the manuscript. Reviewer #2: This seems to me a very important study, as it reveals a reality of the difficulties that exist in the Amazon region. It is necessary to include a map that contextualizes the locations of the communities used in the study, to give more meaning to their location and to better understand how isolated these communities are, not everyone is familiar with the reality of the Amazon region. I would recommend changing the title to: "Healthcare Access Inequalities in Rural and Riverside Quilombola Communities in the Brazilian Amazon: Social, Organizational, and Territorial Determinants". With the original title, it seems as if they were going to analyze three types of communities (quilombola, rural, and riverside) separately, but upon reading the methodology, it becomes clear that they refer to the characteristics of a single community. Line 125: Remove "either" Lines 174-176: Repeated information from lines 161-164. Line 193: Lasso and Ridge (only the first letter capitalized). Lines 202-203: Repetition of information from lines 200-201. Line 205: Replace "when class imbalance was present" with "In cases of class imbalance" Lines 211-212: Replace with "Variables included in clustering were selected to reflect access-related characteristics; post-access outcomes were excluded, as the goal was to describe access profiles" Line 215: Replace with "was fitted for the outcome of healthcare access" Line 223: Replace with "lower socioeconomic status" Line 234: "Among the 517 records in the database, 512 participants". this information already appears in the methodology, in lines 161-164 and 174-176. Line 277: Table 3 is unnecessary because all that information is already repeated in the text, described in lines 267-275. Line 288: Table 4 is unnecessary because all that information is already repeated in the text, described in lines 279-286. Either include only the most important information in the text, or remove the table. Line 281: Change to "Lasso" and "Ridge" Line 322: Table 7 is unnecessary because all that information is already repeated in the text, described in lines 315-321. Line 336: Table 9 is unnecessary because all that information is already repeated in the text, described in lines 330-334. Either include only the most important information in the text, or remove the table. Line 393: Lasso, only the first letter capitalized. Line 415: Correct to "context" Line 429: Replace "assumes more dramatic contours" with "becomes more severe" Question: I would like to know why telehealth services were not discussed further. There is much articles on this topic, even within the Amazon. It is only mentioned in line 475. In my opinion, this is something that should be discussed given the subject matter. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Susan Smith-Doria ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Dear Dr. Valentim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 23 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Angelica Espinosa Miranda, M.D., Ph.D. Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Thank you for submitting the revised version of your manuscript entitled "Healthcare Access Inequalities in Quilombola, Rural, and Riverside Communities in the Brazilian Amazon: Social, Organizational, and Territorial Determinants." Both reviewers acknowledge the relevance of the study and recognize that substantial improvements have been made in response to the initial round of peer review. In particular, the manuscript now provides a clearer description of the analytical methods, includes additional contextual information, and addresses several concerns regarding reporting and presentation. However, after evaluating the revised manuscript and the accompanying response letter, I believe that several reviewer comments have only been partially addressed. Before the manuscript can be considered further, I ask the authors to carefully review the remaining points below. 1. Ensure that every reviewer comment is fully addressed. For several comments, the response letter states that a change was made (e.g., "verified and corrected", "revised", or "removed"), but the revision does not always fully resolve the underlying concern raised by the reviewer. Please ensure that each response addresses not only the requested textual modification but also the scientific rationale behind the reviewer's concern. For example: the conceptual definition of healthcare access should be strengthened by explicitly acknowledging the limitations of the operational definition used in the study; limitations inherent to the cross-sectional design should be discussed more explicitly, particularly regarding the inability to establish temporality or causal relationships. 2. Responses should explain why, not only what. Several responses simply indicate that a modification was performed without explaining how the concern was addressed. Please revise the response letter so that each response clearly explains: what changes were made; where these changes can be found in the manuscript; how these changes address the reviewer's concern. This will greatly facilitate editorial assessment. 3. When a reviewer suggestion is not adopted, provide a scientific justification. The reviewers made some recommendations that the authors elected not to follow (for example, regarding the removal of certain tables). Authors are not required to implement every suggestion. However, whenever a recommendation is not adopted, the response should provide a clear scientific justification rather than simply stating that the table or text was retained. 4. Verify consistency throughout the manuscript. Please carefully verify that all terminology modified in response to reviewer comments has been updated consistently throughout the manuscript. In particular, ensure that revisions made to the study objective are reflected consistently in: the Abstract; the Introduction; the manuscript metadata; the cover letter; and the response letter. Consistency across all submitted documents is important. 5. Data Availability Statement. Please carefully review the revised Data Availability Statement. If the dataset is now publicly available, ensure that: the repository corresponds to the dataset used in the present study; the statement in the manuscript is fully consistent with the information provided in the submission system. If data availability has changed since the original submission, please ensure that this change is clearly explained. In the initial submission the authors stated: "data cannot be shared publicly...". In the reviewers response the answer changed to "there are no ethical restrictions...". It will be important explain it further. 6. Final review of limitations. Although the limitations section has been expanded, I encourage the authors to ensure that it explicitly discusses: possible information bias associated with self-reported variables; potential selection bias related to community-based recruitment; the limited number of communities included in contextual analyses and the implications for generalizability. A balanced discussion of these issues will strengthen the manuscript. Overall, the text improved positively, and I believe the manuscript has the potential to make a valuable contribution to the literature. Addressing the remaining issues above should substantially improve its scientific clarity and facilitate the final editorial decision. I look forward to receiving a carefully revised manuscript together with a detailed point-by-point response explaining how each remaining issue has been addressed. [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Healthcare Access Inequalities in Quilombola Rural and Riverside Communities in the Brazilian Amazon: Associations with Social, Organizational, and Territorial Factors PONE-D-26-10264R2 Dear Dr. Valentim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Angelica Espinosa Miranda, M.D., Ph.D. Academic Editor PLOS One |
| Formally Accepted |
|
PONE-D-26-10264R2 PLOS One Dear Dr. Valentim, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Angelica Espinosa Miranda Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .